Ticker

BSP.TA

BSP - Biological Signal Processing Ltd., a technological company, develops and markets solutions for the non-invasive diagnosis and monitoring of ischemic heart disease in Israel and internationally. The company offers the HyperQ Analyzer Stress, a software module that works with ECG systems; and HyperQ Analyzer Rest, a software module that is used to diagnose patients with chest pain, as well as provides a tool for emergency department teams in detecting acute coronary syndrome. It also provides HyperQ EX-300, a 12-lead stress ECG system to analyze high frequency components of the ECG signal; HyperQ AD-100, an ECG system that integrates with conventional stress ECG system and provides HyperQ analysis; and HyperQ Rest, an ECG system, which records and analyzes patient's ECG at rest to assess the presence of suspected acute coronary syndrome. In addition, the company offers HyperQ Analyzer Stress and Analyzer Rest OEM products that are small-footprint set of software components with application programming interface, which enables ECG data acquisition system to enhance its diagnostic capabilities by incorporating HyperQ analysis. Further, it provides a tool that allows publishing clinical study in the segment of stress ECG tests. BSP - Biological Signal Processing Ltd. was founded in 2000 and is based in Tel-Aviv, Israel.